Search Orphan Drug Designations and Approvals
-
Generic Name: | Interleukin-1 receptor antagonist, human recombinant |
---|---|
Date Designated: | 10/16/1992 |
Orphan Designation: | Prevention and treatment of graft versus host disease in transplant recipients. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Swedish Orphan Biovitrum AB (publ) (SOBI) SE-112 76 Stockholm Sweden The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-